HomeNMLSF • OTCMKTS
add
Restart Life Sciences Corp
Previous close
$0.046
Year range
$0.020 - $0.15
Market cap
1.66M CAD
Avg Volume
5.18K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 285.45K | 47.91% |
Net income | 136.00 | 100.06% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -284.87K | -29.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 169.95K | 2,001.30% |
Total assets | 190.40K | 513.02% |
Total liabilities | 489.47K | -41.85% |
Total equity | -299.07K | — |
Shares outstanding | 33.23M | — |
Price to book | -2.30 | — |
Return on assets | -312.82% | — |
Return on capital | 192.58% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 136.00 | 100.06% |
Cash from operations | -11.30K | 30.92% |
Cash from investing | — | — |
Cash from financing | 15.00K | — |
Net change in cash | 3.70K | 122.65% |
Free cash flow | -537.52K | -1,079.55% |
About
Founded
2004
Headquarters
Website
